newsfilter
← Latest News
GlobeNewswire·

Viracta Therapeutics Announces Orphan Drug Designation Granted by the European Commission to Nana-val for the Treatment of Diffuse Large B-cell Lymphoma

SAN DIEGO, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (NASDAQ:VIRX), a precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide,